Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gyre Therapeutics Inc (GYRE)
Gyre Therapeutics Inc stock price live, this page displays NASDAQ GYRE stock exchange data. View the GYRE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gyre Therapeutics Inc real time stock price chart below.
What Is the Gyre Therapeutics Inc Stock Price Today?
The Gyre Therapeutics Inc stock price today is 6.5200.
What Is the Stock Symbol for Gyre Therapeutics Inc?
The stock ticker symbol for Gyre Therapeutics Inc is GYRE.
Is GYRE the Same as $GYRE?
$GYRE is a common way to refer to the Gyre Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Gyre Therapeutics Inc Trade On?
Gyre Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Gyre Therapeutics Inc a Good Stock to Buy?
Determining whether Gyre Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Gyre Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GYRE quote. (ISIN: US4037831033)
What Is the Gyre Therapeutics Inc Stock Price Today?
The Gyre Therapeutics Inc stock price today is 6.5200.
What Is the Stock Symbol for Gyre Therapeutics Inc?
The stock ticker symbol for Gyre Therapeutics Inc is GYRE.
Is GYRE the Same as $GYRE?
$GYRE is a common way to refer to the Gyre Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Gyre Therapeutics Inc Trade On?
Gyre Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Gyre Therapeutics Inc a Good Stock to Buy?
Determining whether Gyre Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Gyre Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GYRE quote. (ISIN: US4037831033)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.5000
6.8850
52 wk Range
5.4400
9.4200
GYRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.50006.8850
52 wk Range
5.44009.4200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GYRE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
18.6667
Upside
+186.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form S-3 Gyre Therapeutics Inc For: 23 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
- Form 4 Gyre Therapeutics Inc For: 30 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.6667
(+186.30% Upside)
Earnings
Latest Release
May 07, 2026
EPS / Forecast
-0.10 / -0.07
Revenue / Forecast
22.5M / 37.05M
Compare GYRE to Peers and Sector
Metrics to compare | GYRE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGYREPeersSector | |
|---|---|---|---|---|
P/E Ratio | −114.3x | −9.9x | −0.4x | |
PEG Ratio | 0.24 | −0.10 | 0.00 | |
Price / Book | 7.2x | 6.7x | 2.6x | |
Price / LTM Sales | 6.2x | 13.8x | 3.0x | |
Upside (Analyst Target) | 176.1% | 47.1% | 51.7% | |
Fair Value Upside | Unlock | −4.4% | 8.8% | Unlock |
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573, which is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Gyre Therapeutics (GYRE) Stock Price Today?
The Gyre Therapeutics stock price today is 6.5200 USD.
What Stock Exchange Does Gyre Therapeutics Trade On?
Gyre Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Gyre Therapeutics?
The stock symbol for Gyre Therapeutics is "GYRE."
What Is the Gyre Therapeutics Market Cap?
As of today, Gyre Therapeutics market cap is 726.9100M USD.
What Is Gyre Therapeutics's Earnings Per Share (TTM)?
The Gyre Therapeutics EPS (TTM) is -0.0762.
When Is the Next Gyre Therapeutics Earnings Date?
Gyre Therapeutics will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is GYRE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Gyre Therapeutics Stock Split?
Gyre Therapeutics has split 3 times.
How Many Employees Does Gyre Therapeutics Have?
Gyre Therapeutics has 625 employees.
What is the current trading status of Gyre Therapeutics (GYRE)?
As of Jul 12, 2026, Gyre Therapeutics (GYRE) is trading at a price of 6.5200 USD, with a previous close of 6.8600 USD. The stock has fluctuated within a day range of 6.5000 USD to 6.8850 USD, while its 52-week range spans from 5.4400 USD to 9.4200 USD.
What Is Gyre Therapeutics (GYRE) Price Target According to Analysts?
The average 12-month price target for Gyre Therapeutics is 18.6667 USD, with a high estimate of 20 USD and a low estimate of 18 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +186.30% Upside potential.
Industry Spotlight
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.